Cleared Traditional

K022292 - IMPAX DIAGNOSTIC DISPLAY STATION

K022292 is an FDA 510(k) clearance for IMPAX DIAGNOSTIC DISPLAY STATION, manufactured by Agfa Corp.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 59-day FDA review.

K022292 · Agfa Corp. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2002
Decision
59d
Days
Class 2
Risk

K022292 is an FDA 510(k) clearance for the IMPAX DIAGNOSTIC DISPLAY STATION,IMPAX CLINICAL REVIEW STATION,IMPAX FOR CARD.... Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Agfa Corp. (Brevard, US). The FDA issued a Cleared decision on September 12, 2002 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Agfa Corp. devices

FDA 510(k) Submission Details - K022292

510(k) Number K022292 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 15, 2002
Decision Date September 12, 2002
Days to Decision 59 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 107d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1235
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K022292.
ECHO-VIEW 5.X, EASY-VIEW 2.X, OMNI VIEW 2.X, CARDIO-VIEW 1.X, LV ANALYSIS 1.X & SURGICAL VIEW 1.X
K022824 · Tomtec Imaging Systems GmbH · Oct 2002
ACCUSKETCH CARDIAC QUANTITATIVE SYSTEM W/ ADVANCED ANALYSIS COMPONENTS
K023100 · General Electric Medical Systems Information Techn · Oct 2002
CSV12 SOFTWARE VIEWER
K022896 · Acuson Corp. · Oct 2002
FLAT PANEL DISPLAYS, ME SERIES & CCL SERIES
K021738 · Totoku Electric Co., Ltd. · Aug 2002
PATXFER
K021583 · Brainlab AG · Aug 2002
QUANTITATIVE BLOOD POOL SPECT (QBS)
K022428 · Adac Laboratories · Aug 2002